Safety assessment
Safety was assessed as the recording of adverse events from the time of the first injection to three years after the last injection. A research nurse called the patients to assess adverse events 2–5 days after each injection. Safety laboratory parameters were assessed at screening, after the third ILIT injections and after the first pollen season following treatment (Table 2).